You are here: Industry Insights > COVID-19

News List

China's CanSino Bio advances COVID-19 vaccine into phase 2 on preliminary safety data Fiercepharma
April 13, 2020
In the global race to develop an effective vaccine to protect people against the novel coronavirus, China’s CanSino Bio has leapt ahead.
Pfizer finds COVID-19 drug candidate, plots summer testing fiercebiotech
April 13, 2020
Pfizer has found a leading experimental drug candidate against SARS-CoV-2 and is planning to test the drug in the coming months.
Takeda, CSL-led plasma players band together on COVID-19 fiercebiotech
April 13, 2020
There’s more than one way to skin a cat. And in the race to create a plasma-based treatment for COVID-19, industry leaders have decided the best way is to join forces.
BioCryst starts COVID-19 trial of broad-spectrum antiviral fiercebiotech
April 13, 2020
BioCryst Pharmaceuticals has begun enrolling COVID-19 patients in a clinical trial of its antiviral drug galidesivir.
FDA Authorizes Blood Purification Device to Treat COVID-19 americanpharmaceuticalreview
April 13, 2020
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization for a blood purification system to treat patients 18 years of age or olderwith confirmed Coronavirus Disease ...
Avacta, Cytiva Collaborating on COVID-19 Rapid Test americanpharmaceuticalreview
April 13, 2020
Avacta Group has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences.
Affiliate of Lupus Research Alliance Developing Study Focused on Lupus Patients and COVID-19 americanpharmaceuticalreview
April 13, 2020
Lupus Therapeutics announced is embarking on a clinical study to assess the potential benefit of hydroxychloroquine and/or other lupus therapies in preventing or reducing the symptoms of COVID-19 in people with lupus.
Viriom Initiates Phase 2 Clinical Study of Elsulfavirine for COVID-19 americanpharmaceuticalreview
April 13, 2020
Viriom announced the initiation of a Phase 2 clinical study to evaluate the efficacy of elsulfavirine in adults with moderate manifestations of COVID-19 (novel coronavirus).
Pfizer identifies lead coronavirus drug candidate pharmaceutical-technology
April 13, 2020
Pfizer has announced progress in its research programme to develop antivirals and vaccine for the Covid-19 coronavirus infection.
Sesderma Laboratories communicates the effectiveness of Lactyferrin Forte Solution in the prevention and treatment of COVID-19 infection expresspharma
April 13, 2020
Sesderma, a Spanish company specializes in Nanotechnology, has managed to produce an effective drug named Lactyferrin (LF) to counter the COVID-19 strain.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page